Warnings About Transvaginal Mesh
The Food and Drug Administration warned in July 2011 that patients who are treated with transvaginal surgical mesh products face an increased risk of serious complications compared to those who are treated with traditional surgical methods. Transvaginal mesh is used by surgeons to treat patients with stress urinary incontinence (SUI) and pelvic organ prolapse (POP).
Concerns about the safety of transvaginal mesh first arose in October 2008, when the FDA issued a warning about the risk complications for patients who receive surgical mesh to treat SUI or POP. After receiving thousands of reports from patients who had experienced problems with transvaginal mesh products, the FDA issued a second warning stating that the complications from mesh products were far more common than had been previously thought.
Complications from Transvaginal Mesh
According to the FDA’s warning about transvaginal surgical mesh, the most commonly reported with the product was erosion of the mesh through the walls of the vagina. In many cases, patients who experienced problems with transvaginal mesh were forced to undergo multiple surgeries in order to fix complications caused by surgical mesh. Other commonly reported complications include:
- Pain during sexual intercourse (dyspareunia)
- Organ perforation
- Urinary problems
According to a survey conducted in November 2011 at an annual meeting of the American Association of Gynecologic Laparoscopists, many doctors have stopped using transvaginal mesh in the wake of the FDA’s warning due to increased risk of complications compared to traditional surgery. According to the FDA, it may be impossible to fully correct some of the problems that occur after transvaginal mesh surgery, even in cases where patients undergo multiple surgeries to correct these problems.
Hundreds of patients have filed transvaginal mesh lawsuits against the manufacturers of these products, which include Johnson & Johnson, Boston Scientific, C.R. Bard, Gynecare, and American Medical Systems. A class action lawsuit on behalf of women who were treated with transvaginal mesh has also been filed.
In July 2012, jurors in California awarded $3.6 million to a woman who developed chronic pain and other complications after undergoing transvaginal mesh surgery to treat urinary incontinence. The case was the first surgical mesh lawsuit to go to trial.
If you or a loved one was treated with transvaginal surgical mesh and have suffered complications from this product, you may be eligible to file a lawsuit. For more information and to find out if you are eligible to file a case, contact the lawyers at Heygood, Orr & Pearson by calling toll-free at 1-877-447-9001 or by completing the free case evaluation form located on this page.